Suleyman is one of the three co-founders of Artificial Intelligence / Machine Learning company DeepMind Technologies, and started out as its Chief Product Officer. The company quickly established itself as one of the leaders in the AI sector and was backed by  Founders Fund. Elon Musk, and Scott Banister amongst others.

In 2014 DeepMind was acquired by Google for a reported £400 million — the company's largest acquisition in Europe to date. Following the acquisition, Suleyman became Head of Applied AI at DeepMind, taking on responsibility for integrating the company's technology across a wide range of Google products.

In February 2016 Suleyman launched DeepMind Health at the Royal Society of Medicine.